Issues with foam are suspected in recalled Philips model.
The Food and Drug Administration (FDA) announced last week that it has received 48,000 reports for faulty ventilators and sleep apnea machines in the last three months, twice the number of reports the agency usually gets in one quarter. “A wide range of injuries have been reported in these (reports) including cancer, pneumonia, asthma, other respiratory problems, infection, headache, cough, difficulty breathing, dizziness, nodules, and chest pain,” the FDA said.
The reports have been associated with foam breakdown in machines made by the Philips company, which is approximately halfway through a recall of 5.5 million of their various respirators. The reports are not proof that Philips devices were responsible, but several issues within the company have led to the announcement that the CEO will be replaced.
As the Lord Leads, Pray with Us…
- For FDA officials as they seek to keep the American public safe.
- For Commissioner Califf as he oversees FDA operations and reviews.
- For healing for those affected by faulty ventilators and sleep apnea machines.
Sources: The Hill, Reuters
